Cognitive Dysfunction

Displaying 101 - 150 of 162CSV
Quaye, E., Galecki, A. T., Tilton, N., Whitney, R., Briceño, E. M., Elkind, M. S. V., Fitzpatrick, A. L., Gottesman, R. F., Griswold, M., Gross, A. L., Heckbert, S. R., Hughes, T. M., Longstreth, W. T., Sacco, R. L., Sidney, S., Windham, B. G., Yaffe, K., & Levine, D. A. (2023). Association of Obesity With Cognitive Decline in Black and White Americans. Neurology, 100(2). https://doi.org/10.1212/wnl.0000000000201367
Publication Date
Petrella, J. R., Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., & Doraiswamy, P. M. (2023). Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer’s Disease: A 78-week Randomized Controlled Trial. Journal of Alzheimer’s Disease, 91(1), 483–494. https://doi.org/10.3233/jad-220946
Publication Date
Chen, C., Yang, K., Nan, H., Unverzagt, F., McClure, L. A., Irvin, M. R., Judd, S., Cushman, M., Kamin Mukaz, D., Klaunig, J. E., D’Alton, M. E., & Kahe, K. (2023). Associations of Telomere Length and Change With Cognitive Decline Were Modified by Sex and Race: The REGARDS Study. American Journal of Alzheimer’s Disease & Other Dementias®, 38. https://doi.org/10.1177/15333175231175797
Publication Date
Hani Hojjati, S., Butler, T. A., Chiang, G. C., Habeck, C., RoyChoudhury, A., Feiz, F., Shteingart, J., Nayak, S., Ozoria, S., Fernández, A., Stern, Y., Luchsinger, J. A., Devanand, D. P., & Razlighi, Q. R. (2023). Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness. NeuroImage: Clinical, 38, 103409. https://doi.org/10.1016/j.nicl.2023.103409
Publication Date
Wharton, W., Anderson, A., Hayden, K. M., Carmichael, O. T., Clark, J. M., Luchsinger, J. A., Espeland, M., & Yasar, S. (2022). Effect of renin‐angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial. Diabetes, Obesity and Metabolism, 24(12), 2443–2453. Portico. https://doi.org/10.1111/dom.14838
Publication Date
Jiménez-Balado, J., Corlier, F., Habeck, C., Stern, Y., & Eich, T. (2022). Effects of white matter hyperintensities distribution and clustering on late-life cognitive impairment. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-06019-8
Publication Date
Mielke, M. M., Aggarwal, N. T., Vila‐Castelar, C., Agarwal, P., Arenaza‐Urquijo, E. M., Brett, B., Brugulat‐Serrat, A., DuBose, L. E., Eikelboom, W. S., Flatt, J., Foldi, N. S., Franzen, S., Gilsanz, P., Li, W., McManus, A. J., van Lent, D. M., Milani, S. A., Shaaban, C. E., … Stites, S. D. (2022). Consideration of sex and gender in Alzheimer’s disease and related disorders from a global perspective. Alzheimer’s & Dementia, 18(12), 2707–2724. Portico. https://doi.org/10.1002/alz.12662
Publication Date
Manly, J. J., Jones, R. N., Langa, K. M., Ryan, L. H., Levine, D. A., McCammon, R., Heeringa, S. G., & Weir, D. (2022). Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US. JAMA Neurology, 79(12), 1242. https://doi.org/10.1001/jamaneurol.2022.3543
Publication Date
Xiang, X., Tang, X., Yu, Y., Xie, S., Liu, L., Chen, M., Zhang, R., Kang, X., Zheng, Y., Yang, G., Gan, S., & Zhu, S. (2022). Role of lipocalin-2 in surgery-induced cognitive decline in mice: a signal from neuron to microglia. Journal of Neuroinflammation, 19(1). https://doi.org/10.1186/s12974-022-02455-5
Publication Date
Luquez, T., Gaur, P., Kosater, I. M., Lam, M., Lee, D. I., Mares, J., Paryani, F., Yadav, A., & Menon, V. (2022). Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease. Genome Medicine, 14(1). https://doi.org/10.1186/s13073-022-01136-5
Publication Date
Choi, H., Elkind, M. S. V., Longstreth, W. T., Boehme, A. K., Hafen, R., Hoyt, E. J., & Thacker, E. L. (2022). Epilepsy, Vascular Risk Factors, and Cognitive Decline in Older Adults. Neurology, 99(21). https://doi.org/10.1212/wnl.0000000000201187
Publication Date
McMillan, C. T., Wuu, J., Rascovsky, K., Cosentino, S., Grossman, M., Elman, L., Quinn, C., Rosario, L., Stark, J. H., Granit, V., Briemberg, H., Chenji, S., Dionne, A., Genge, A., Johnston, W., Korngut, L., Shoesmith, C., Zinman, L., … Benatar, M. (2022). Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(7–8), 517–526. https://doi.org/10.1080/21678421.2022.2039713
Publication Date
Calcetas, A. T., Thomas, K. R., Edmonds, E. C., Holmqvist, S. L., Edwards, L., Bordyug, M., Delano-Wood, L., Brickman, A. M., Bondi, M. W., Bangen, K. J., & for the Alzheimer’s Disease Neuroimaging Initiative. (2022). Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment. Neurobiology of Aging, 118, 1–8. https://doi.org/10.1016/j.neurobiolaging.2022.06.002
Publication Date
Buckles, V. D., Xiong, C., Bateman, R. J., Hassenstab, J., Allegri, R., Berman, S. B., Chhatwal, J. P., Danek, A., Fagan, A. M., Ghetti, B., Goate, A., Graff‐Radford, N., Jucker, M., Levin, J., Marcus, D. S., Masters, C. L., McCue, L., McDade, E., … Mori, H. (2021). Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer disease. Alzheimer’s & Dementia, 18(10), 1754–1764. Portico. https://doi.org/10.1002/alz.12505
Publication Date
Chapman, S., Weiss, D., Broulíková, H. M., Sunderaraman, P., Barker, M. S., Joyce, J. L., Azar, M., McKeague, I., Kriesl, W. C., & Cosentino, S. (2022). Examining the Role of Aging Perceptions in Subjective Cognitive Decline. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/wad.0000000000000518
Publication Date
Seto, M., Weiner, R. L., Dumitrescu, L., Mahoney, E. R., Hansen, S. L., Janve, V., Khan, O. A., Liu, D., Wang, Y., Menon, V., De Jager, P. L., Schneider, J. A., Bennett, D. A., Gifford, K. A., Jefferson, A. L., & Hohman, T. J. (2022). RNASE6 is a novel modifier of APOE-ε4 effects on cognition. Neurobiology of Aging, 118, 66–76. https://doi.org/10.1016/j.neurobiolaging.2022.06.011
Publication Date
Chandran, M., Yeh, L. T. L., de Jong, M. C., Bilezikian, J. P., & Parameswaran, R. (2022). Cognitive deficits in primary hyperparathyroidism – what we know and what we do not know: A narrative review. Reviews in Endocrine and Metabolic Disorders, 23(5), 1079–1087. https://doi.org/10.1007/s11154-022-09750-9
Publication Date
Walsh, C. E., Yang, Y. C., Oi, K., Aiello, A., Belsky, D., Harris, K. M., & Plassman, B. L. (2022). Age Profiles of Cognitive Decline and Dementia in Late Life in the Aging, Demographics, and Memory Study. The Journals of Gerontology: Series B, 77(10), 1880–1891. https://doi.org/10.1093/geronb/gbac038
Publication Date
Barreto Chang, O. L., Kreuzer, M., Morgen, D. F., Possin, K. L., & García, P. S. (2022). Ketamine Associated Intraoperative Electroencephalographic Signatures of Elderly Patients With and Without Preoperative Cognitive Impairment. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000005875
Publication Date
Sugden, K., Caspi, A., Elliott, M. L., Bourassa, K. J., Chamarti, K., Corcoran, D. L., Hariri, A. R., Houts, R. M., Kothari, M., Kritchevsky, S., Kuchel, G. A., Mill, J. S., Williams, B. S., Belsky, D. W., & Moffitt, T. E. (2022). Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia. Neurology, 99(13). https://doi.org/10.1212/wnl.0000000000200898
Publication Date
Benoit, L. J., Canetta, S., & Kellendonk, C. (2022). Thalamocortical Development: A Neurodevelopmental Framework for Schizophrenia. Biological Psychiatry, 92(6), 491–500. https://doi.org/10.1016/j.biopsych.2022.03.004
Publication Date
Comfort, N., Wu, H., De Hoff, P., Vuppala, A., Vokonas, P. S., Spiro, A., Weisskopf, M., Coull, B. A., Laurent, L. C., Baccarelli, A. A., & Schwartz, J. (2022). Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study. Aging, 14(17), 6859–6886. https://doi.org/10.18632/aging.204268
Publication Date
Chanti-Ketterl, M., Stebbins, R. C., Obhi, H. K., Belsky, D. W., Plassman, B. L., & Yang, Y. C. (2021). Sex Differences in the Association Between Metabolic Dysregulation and Cognitive Aging: The Health and Retirement Study. The Journals of Gerontology: Series A, 77(9), 1827–1835. https://doi.org/10.1093/gerona/glab285
Publication Date
Lao, P. J., Boehme, A. K., Morales, C., Laing, K. K., Chesebro, A., Igwe, K. C., Gutierrez, J., Gu, Y., Stern, Y., Schupf, N., Manly, J. J., Mayeux, R., & Brickman, A. M. (2022). Amyloid, cerebrovascular disease, and neurodegeneration biomarkers are associated with cognitive trajectories in a racially and ethnically diverse, community-based sample. Neurobiology of Aging, 117, 83–96. https://doi.org/10.1016/j.neurobiolaging.2022.05.004
Publication Date
Brewster, K. K., Deal, J. A., Lin, F. R., & Rutherford, B. R. (2022). Considering hearing loss as a modifiable risk factor for dementia. Expert Review of Neurotherapeutics, 22(9), 805–813. https://doi.org/10.1080/14737175.2022.2128769
Publication Date
Pa, J., Aslanyan, V., Casaletto, K. B., Rentería, M. A., Harrati, A., Tom, S. E., Armstrong, N., Rajan, K., Avila-Rieger, J., Gu, Y., Schupf, N., Manly, J. J., Brickman, A., & Zahodne, L. (2022). Effects of Sex, APOE4, and Lifestyle Activities on Cognitive Reserve in Older Adults. Neurology, 99(8). https://doi.org/10.1212/wnl.0000000000200675
Publication Date
Rabin, J. S., Nichols, E., La Joie, R., Casaletto, K. B., Palta, P., Dams-O’Connor, K., Kumar, R. G., George, K. M., Satizabal, C. L., Schneider, J. A., Pa, J., & Brickman, A. M. (2022). Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain, 145(8), 2823–2833. https://doi.org/10.1093/brain/awac178
Publication Date
Janelidze, S., Christian, B. T., Price, J., Laymon, C., Schupf, N., Klunk, W. E., Lott, I., Silverman, W., Rosas, H. D., Zaman, S., Mapstone, M., Lai, F., Ances, B. M., Handen, B. L., & Hansson, O. (2022). Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers. JAMA Neurology, 79(8), 797. https://doi.org/10.1001/jamaneurol.2022.1740
Publication Date
Kamath, V., Senjem, M. L., Spychalla, A. J., Chen, H., Palta, P., Mosley, T. H., Windham, B. G., Griswold, M., Knopman, D. S., Gottesman, R. F., Jack, C. R., Sharrett, A. R., & Schneider, A. L. C. (2022). The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 89(1), 233–245. https://doi.org/10.3233/jad-220228
Publication Date
Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Trittschuh, E. H., Mez, J., Kaczorowski, C. C., Hernandez Saucedo, H., Widaman, K. F., Buckley, R. F., Properzi, M. J., … Hohman, T. J. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554. https://doi.org/10.1093/brain/awac177
Publication Date
Cosentino, S., & Shih, L. C. (2022). Does essential tremor increase risk of cognitive impairment and dementia? Yes. Essential Tremor: Current Concepts and Controversies, 195–231. https://doi.org/10.1016/bs.irn.2022.02.011
Publication Date
Tsiakiri, A., Koutzmpi, V., Megagianni, S., Toumaian, M., Geronikola, N., Despoti, A., Kanellopoulou, S., Arampatzi, X., Margioti, E., Davila, A., Zoi, P., Kalligerou, F., Liozidou, A., Tsapanou, A., & Sakka, P. (2022). Remote neuropsychological evaluation of older adults. Applied Neuropsychology: Adult, 31(5), 796–803. https://doi.org/10.1080/23279095.2022.2074850
Publication Date
Kim, H., Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., & Goldberg, T. E. (2022). The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer’s Disease Risks. Journal of Alzheimer’s Disease, 87(4), 1567–1580. https://doi.org/10.3233/jad-215417
Publication Date
Zeki Al Hazzouri, A., Jawadekar, N., Grasset, L., Kaiser, P., Kezios, K., Calonico, S., Glymour, M., Hirsch, C., Arnold, A. M., Varadhan, R., & Odden, M. C. (2021). Statins and Cognitive Decline in the Cardiovascular Health Study: A Comparison of Different Analytical Approaches. The Journals of Gerontology: Series A, 77(5), 994–1001. https://doi.org/10.1093/gerona/glab220
Publication Date
Libon, D. J., Swenson, R., Lamar, M., Price, C. C., Baliga, G., Pascual-Leone, A., Au, R., Cosentino, S., & Andersen, S. L. (2022). The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions. Journal of Alzheimer’s Disease, 87(4), 1419–1432. https://doi.org/10.3233/jad-220096
Publication Date
Kálmán, J., Devanand, D. P., Gosztolya, G., Balogh, R., Imre, N., Tóth, L., Hoffmann, I., Kovács, I., Vincze, V., & Pákáski, M. (2022). Temporal Speech Parameters Detect Mild Cognitive Impairment in Different Languages: Validation and Comparison of the Speech-GAP Test® in English and Hungarian. Current Alzheimer Research, 19(5), 373–386. https://doi.org/10.2174/1567205019666220418155130
Publication Date
Arce Rentería, M., Manly, J. J., Vonk, J. M. J., Mejia Arango, S., Michaels Obregon, A., Samper-Ternent, R., Wong, R., Barral, S., & Tosto, G. (2021). Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico. Journal of the International Neuropsychological Society, 28(4), 351–361. https://doi.org/10.1017/s1355617721000539
Publication Date
Zammit, A. R., Yu, L., Petyuk, V., Schneider, J. A., De Jager, P. L., Klein, H.-U., Bennett, D. A., & Buchman, A. S. (2022). Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology, 98(13). https://doi.org/10.1212/wnl.0000000000200017
Publication Date
Irace, A. L., Armstrong, N. M., Deal, J. A., Chern, A., Ferrucci, L., Lin, F. R., Resnick, S. M., & Golub, J. S. (2021). Longitudinal Associations of Subclinical Hearing Loss With Cognitive Decline. The Journals of Gerontology: Series A, 77(3), 623–631. https://doi.org/10.1093/gerona/glab263
Publication Date
Nicholson, S., Baccarelli, A., & Prada, D. (2022). Role of brain extracellular vesicles in air pollution-related cognitive impairment and neurodegeneration. Environmental Research, 204, 112316. https://doi.org/10.1016/j.envres.2021.112316
Publication Date
Gomez, G. T., Gottesman, R. F., Gabriel, K. P., Palta, P., Gross, A. L., Soldan, A., Albert, M. S., Sullivan, K. J., Jack, C. R., Knopman, D. S., Windham, B. G., & Walker, K. A. (2021). The association of motoric cognitive risk with incident dementia and neuroimaging characteristics: The Atherosclerosis Risk in Communities Study. Alzheimer’s & Dementia, 18(3), 434–444. Portico. https://doi.org/10.1002/alz.12412
Publication Date
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Aarsland, D., Alcolea, D., Altomare, D., von Arnim, C., Baiardi, S., Baldeiras, I., Barthel, H., Bateman, R. J., Van Berckel, B., Binette, A. P., Blennow, K., Boada, M., … Zetterberg, H. (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology, 79(3), 228. https://doi.org/10.1001/jamaneurol.2021.5216
Publication Date
Zheng, Y., Habes, M., Gonzales, M., Pomponio, R., Nasrallah, I., Khan, S., Vaughan, D. E., Davatzikos, C., Seshadri, S., Launer, L., Sorond, F., Sedaghat, S., Wainwright, D., Baccarelli, A., Sidney, S., Bryan, N., Greenland, P., Lloyd-Jones, D., Yaffe, K., & Hou, L. (2022). Mid-life epigenetic age, neuroimaging brain age, and cognitive function: coronary artery risk development in young adults (CARDIA) study. Aging, 14(4), 1691–1712. https://doi.org/10.18632/aging.203918
Publication Date
Doraiswamy, P. M., Goldberg, T. E., Qian, M., Linares, A. R., Nwosu, A., Nino, I., D’Antonio, J., Phillips, J., Ndouli, C., Hellegers, C., Michael, A. M., Petrella, J. R., Andrews, H., Sneed, J., & Devanand, D. P. (2022). Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 86(3), 1131–1136. https://doi.org/10.3233/jad-220015
Publication Date
Carlson, S., Kim, H., Devanand, D. P., & Goldberg, T. E. (2022). Novel approaches to measuring neurocognitive functions in Alzheimer’s disease clinical trials. Current Opinion in Neurology, 35(2), 240–248. https://doi.org/10.1097/wco.0000000000001041
Publication Date
Johnson, E. C. B., Carter, E. K., Dammer, E. B., Duong, D. M., Gerasimov, E. S., Liu, Y., Liu, J., Betarbet, R., Ping, L., Yin, L., Serrano, G. E., Beach, T. G., Peng, J., De Jager, P. L., Haroutunian, V., Zhang, B., Gaiteri, C., Bennett, D. A., Gearing, M., … Seyfried, N. T. (2022). Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nature Neuroscience, 25(2), 213–225. https://doi.org/10.1038/s41593-021-00999-y
Publication Date
Tsapanou, A., Mourtzi, N., Charisis, S., Hatzimanolis, A., Ntanasi, E., Kosmidis, M. H., Yannakoulia, M., Hadjigeorgiou, G., Dardiotis, E., Sakka, P., Stern, Y., & Scarmeas, N. (2021). Sleep Polygenic Risk Score Is Associated with Cognitive Changes over Time. Genes, 13(1), 63. https://doi.org/10.3390/genes13010063
Publication Date